Cancer Reports’ Post

New #JITC article: Tumor cell-released autophagosomes (TRAPs) induce PD-L1-decorated NETs that suppress T-cell function to promote breast cancer pulmonary metastasis https://bit.ly/3VKrU56

#publishedineinstein This study set out to evaluate the effect of intrathecal #chemotherapy on the overall survival and clinical benefits in patients with metastatic breast cancer and meningeal carcinomatosis.   Full article at https://lnkd.in/dg4DXz8p   #visualabstract #journaleinstein #breastneoplasm #meningealcarcinomatosis #intrathecalchemotherapy #neurologicmanifestations

In patients with locally advanced colon cancer, prophylactic HIPEC in addition to surgical resection and adjuvant systemic chemotherapy seems to significantly improve the locoregional recurrence rate in high-risk subgroups. #COLOPEC and #HIPECT4 trials. #hospitalreinasofia #annalsofoncology #esmoGI #ESMO #aecirujanos https://lnkd.in/dfrqyvNG

#News 🎉ENHERTU Granted Breakthrough Therapy Designation in U.S. for Certain Patients with HER2 Low or HER2 Ultralow Metastatic Breast Cancer® ENHERTU (trastuzumab deruxtecan) is a HER2 directed ADC. HER2 is a tyrosine kinase receptor growth-promoting protein expressed on the surface of many types of tumors, including breast cancer. 👉learn more about our HER2 catalog: https://lnkd.in/gPyAytK2 📧 mkt.genomeditech@gmail.com #antibodydiscovery #antibodytherapeutics #celllinedevelopment #cancertreatment #antibodies #drugdiscovery #breakthrough #HER2

An In Silico Analysis Identified Members of the Pleckstrin Homology-Like Domain, Family B (PHLDB family) as Potential Prognostic and Predictive Biomarkers of Treatment Response in Breast Cancer Patients   You can see the free full text of the research by Renan Gomes do Nascimento et al.   Link : https://lnkd.in/dN4Bqzxg   #Breast #cancer #PHLDB #silicoanalysis #biomarkers

New Global Analysis: Top Five Studied Diseases in 2023 Based on a global analysis of all clinical trials conducted in 2023, the most studied diseases/indications are: #1 Breast Cancer #2 Solid Tumor #3 Stroke #4 Covid-19 #5 Prostate Cancer https://lnkd.in/eY96cUzE Phesi #dataanalytics #clinicalresearch #breastcancer #solidtumors #stroke #clinicaldevelopment #covid19 #prostatecancer

New Global Analysis: Top Five Studied Diseases in 2023 Based on a global analysis of all clinical trials conducted in 2023, the most studied diseases/indications are: #1 Breast Cancer #2 Solid Tumor #3 Stroke #4 Covid-19 #5 Prostate Cancer https://lnkd.in/ePK982PY Phesi #dataanalytics #clinicalresearch #breastcancer #solidtumors #stroke #clinicaldevelopment #covid19 #prostatecancer

Revolutionizing colorectal cancer screening with SCHEBO M2PK: Say goodbye to unnecessary colonoscopies! Our 2-in-1 quick stool test detects both bleeding and non-bleeding tumors, offering a non-invasive, efficient alternative. Stay ahead of the curve with early detection. #ColorectalCancerAwareness #InnovativeScreening #HealthUAE #SCHEBO #M2PK

Association of effective dose to immune cells and vertebral marrow dose with hematologic toxicity during neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma https://lnkd.in/enbaGQ-K 🧪 #CancerResearch #Pathophysiology #CancerPrevention #CancerDiagnosis #CancerTreatment #Cancer #Oncology

Introducing the 3rd Episode of ProNews' 4th Edition: "Proton therapy in Hepatocellular CA" In this episode, we dive into the most advanced treatment of hepatocellular carcinoma (liver cancer). Liver cancer, often associated with chronic liver disease, can benefit significantly from advanced proton therapy. Click here to watch video: https://lnkd.in/dsyn74tA Dr Ashu Abhishek Arjunan Manikandan #APCC #ProNews #ProtonTherapy #LiverCancer